GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
FISH, COLIN JOHN
申请号：
CA2972939
公开号：
CA2972939A1
申请日:
2016.01.11
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
This invention provides a pharmaceutical combination comprising biphenyl-2-ylcarbamic acid 1-[2-(2- chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl)ethyl]piperidin-4-yl ester, or a pharmaceutically acceptable salt thereof, and fluticasone furoate, and use of the pharmaceutical combination in therapy, for example in the treatment or prophylaxis of respiratory disorders or diseases, for example pulmonary disorders such as chronic obstructive pulmonary disease (COPD) asthma and Asthma-COPD Overlap Syndrome (ACQS).
